Evidence map›Paper›PMID 36756076›Full record

ArticleJournal of clinical and translational science2022

Research Ambassador Program: An innovative educational approach to addressing underrepresentation of minority populations in clinical research.

Nicole Wolfe, Mayra Rubio-Diaz, Alma Garcia, Sara Calderon, Michele D Kipke

Abstract read
In one paragraph

Article in Journal of clinical and translational science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. From Dialogue to Action: Community Recommendations for Inclusive Research Participation Among Underrepresented Populations.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  3. Article
  4. Article
  5. TheFrontiers in public health · 2025
    Article
  6. Barriers to Timely Diagnosis of Eosinophilic Gastrointestinal Diseases.The journal of allergy and clinical immunology. In practice · 2024
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nicole WolfeSouthern California Clinical and Translational Science Institute, University of Southern California, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0002-3856-216X
Mayra Rubio-DiazSouthern California Clinical and Translational Science Institute, University of Southern California, Los Angeles, CA, USA.
Alma GarciaSouthern California Clinical and Translational Science Institute, University of Southern California, Los Angeles, CA, USA.
Sara CalderonSouthern California Clinical and Translational Science Institute, University of Southern California, Los Angeles, CA, USA.
Michele D KipkeSouthern California Clinical and Translational Science Institute, University of Southern California, Los Angeles, CA, USA.

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
NCATS NIH HHS UL1 TR001855
6 · The paper itself

Abstract

Clinical trial participation among historically underrepresented populations remains low in large part due to mistrust of academic institutions and research investigators. Mistrust may be ever greater today given misinformation related to COVID-19. The Research Ambassador Program is an interactive educational workshop delivered by

Indexed as

Clinical researchcommunity engagementcommunity health workerseducationhealth disparities

Identifiers

PMID36756076
PMCPMC9879877

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.